TP53BP2 and acute leukemia: Subcohort analysis of bone marrow aspirates (n = 26) versus peripheral blood samples (n = 30), derived from consented patients with newly diagnosed acute leukemia, did not reveal significant differences in ASPP2 expression levels (p = 0.75; medianbone marrow 3.3, min. 0.0, max.